Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 29, 2015 - Issue 22
298
Views
9
CrossRef citations to date
0
Altmetric
Short Communication

Alkaloid extracts of Ficus species and palm oil-derived tocotrienols synergistically inhibit proliferation of human cancer cells

, &
Pages 2137-2140 | Received 09 Oct 2014, Accepted 20 Nov 2014, Published online: 17 Dec 2014

References

  • Constantinou C, Papas A, Constantinou AI. 2008. Vitamin E and cancer: an insight into the anticancer activities of vitamin E isomers and analogs. Int J Cancer. 123:739–752.
  • Cragg GM, Newman DJ. 2005. Plants as a source of anti-cancer agents. J Ethnopharmacol. 100:72–79.
  • Lansky EP, Paavilainen HM, Pawlus AD, Newman RA. 2008. Ficus spp. (fig): ethnobotany and potential as anticancer and anti-inflammatory agents. J Ethnopharmacol. 119:195–213.
  • Saraste A, Pulkki K. 2000. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res. 45:528–537.
  • Subramaniam G, Ang KKH, Ng S, Buss AD, Butler MS. 2009. A benzopyrroloisoquinoline alkaloid from Ficus fistulosa. Phytochem Lett. 2:88–90.
  • Suffness M, Pezzuto JM. 1990. Assays related to cancer drug discovery. In: Hostettmann K, editor. Methods in plant biochemistry: assays for bioactivity. 6th ed. London: Academic Press; p. 71–133.
  • Zhang HJ, Tamez PA, Aydogmus Z, Tan GT, Saikawa Y, Hashimoto K, Nakata M, Hung NV, Xuan le T, Cuong NM, et al. 2002. Antimalarial agents from plants. III. Trichothecenes from Ficus fistulosa and Rhaphidophora decursiva. Planta Med. 68:1088–1091.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.